Thus, we generated double-knockout mice with hepatocyte-specific deletion of JNK2 and NEMOΔHepa and subsequently examined liver cancer progression in NEMOΔHepa, NEMO/JNK2ΔHepa mice, and their corresponding littermate controls (floxed mice). Here, MAPK9 is linked to liver cancer.